HUT47854A - Release in biological liquids of materials mediating the protection of host organism by systemic two-stranded rna treatment - Google Patents

Release in biological liquids of materials mediating the protection of host organism by systemic two-stranded rna treatment

Info

Publication number
HUT47854A
HUT47854A HU884319A HU431988A HUT47854A HU T47854 A HUT47854 A HU T47854A HU 884319 A HU884319 A HU 884319A HU 431988 A HU431988 A HU 431988A HU T47854 A HUT47854 A HU T47854A
Authority
HU
Hungary
Prior art keywords
systemic
release
mediating
protection
materials
Prior art date
Application number
HU884319A
Other languages
English (en)
Inventor
William A Carter
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of HUT47854A publication Critical patent/HUT47854A/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
HU884319A 1987-08-12 1988-08-11 Release in biological liquids of materials mediating the protection of host organism by systemic two-stranded rna treatment HUT47854A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8422787A 1987-08-12 1987-08-12

Publications (1)

Publication Number Publication Date
HUT47854A true HUT47854A (en) 1989-04-28

Family

ID=22183617

Family Applications (1)

Application Number Title Priority Date Filing Date
HU884319A HUT47854A (en) 1987-08-12 1988-08-11 Release in biological liquids of materials mediating the protection of host organism by systemic two-stranded rna treatment

Country Status (19)

Country Link
EP (1) EP0308066B1 (hu)
JP (1) JPH01131119A (hu)
KR (1) KR0131879B1 (hu)
CN (1) CN1050995C (hu)
AT (1) ATE132041T1 (hu)
AU (3) AU2053588A (hu)
CA (1) CA1327002C (hu)
DE (1) DE3854829T2 (hu)
DK (1) DK449888A (hu)
FI (1) FI883763A (hu)
HU (1) HUT47854A (hu)
IE (1) IE72103B1 (hu)
IL (1) IL87413A0 (hu)
NO (1) NO883594L (hu)
NZ (1) NZ225799A (hu)
OA (1) OA08901A (hu)
PT (1) PT88266B (hu)
RU (1) RU1834663C (hu)
ZA (1) ZA885967B (hu)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE122402T1 (de) * 1987-09-04 1995-05-15 Hem Pharma Corp Diagnose von mangelzuständen doppelsträngiger rns.
US5593973A (en) * 1987-09-04 1997-01-14 Hemispherx Biopharma Inc. Treatment of viral hepatitis with mismatched dsRNA
US4963532A (en) * 1987-11-25 1990-10-16 Hem Research, Inc. dsRNA-based prevention of viral escape
EP0378621A4 (en) * 1988-05-23 1991-08-28 Steffen Gay Diagnostics and therapy for rheumatoid arthritis
EP0473576A4 (en) * 1989-05-19 1993-03-10 Hem Research, Inc. Short therapeutic dsrna of defined structure
ZA908037B (en) * 1989-10-11 1991-09-25 Hem Res Inc Protection from shock subsequent to injury by double-standed rnas
JP3150967B2 (ja) * 1989-10-11 2001-03-26 エイチイーエム リサーチ，インコーポレイティド 二本鎖ｒｎａによる損傷に続くショックからの保護
AU647754B2 (en) * 1989-10-16 1994-03-31 Hem Research, Inc. Diagnosis and treatment of neuro-cognitive disorders associated with systemic immunological malfunction
EP0654998A1 (en) * 1991-09-26 1995-05-31 Hem Pharmaceuticals Corp. METHOD OF NEUTRALIZING IL-1 USING dsRNAs
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
EP1857549B1 (en) 1998-03-20 2018-10-17 Commonwealth Scientific and Industrial Research Organisation Control of gene expression
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
EP1147204A1 (en) 1999-01-28 2001-10-24 Medical College Of Georgia Research Institute, Inc. Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
CA2369944A1 (en) 2001-01-31 2002-07-31 Nucleonics Inc. Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
WO2003087367A2 (en) * 2002-04-18 2003-10-23 Lynkeus Biotech Gmbh Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye
US7148342B2 (en) 2002-07-24 2006-12-12 The Trustees Of The University Of Pennyslvania Compositions and methods for sirna inhibition of angiogenesis
AU2003260489A1 (en) 2002-09-04 2004-03-29 Novartis Ag Treatment of neurological disorders by dsrna adminitration
JP2010520284A (ja) * 2007-03-05 2010-06-10 ユタ ステイト ユニバーシティ Ｔｏｌｌ様受容体３（ＴＬＲ３）の限定アゴニスト
CA2745832A1 (en) 2008-12-04 2010-06-10 Opko Ophthalmics, Llc Compositions and methods for selective inhibition of pro-angiogenic vegf isoforms
CN109355334A (zh) * 2018-12-06 2019-02-19 江苏省农业科学院 一种制备聚肌胞的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)
AU1820388A (en) * 1987-07-17 1989-01-19 Hem Research, Inc. Double stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles

Also Published As

Publication number Publication date
CA1327002C (en) 1994-02-15
DE3854829T2 (de) 1996-08-14
IL87413A0 (en) 1989-01-31
CN1050995C (zh) 2000-04-05
IE882399L (en) 1989-02-12
AU1736792A (en) 1992-07-30
DK449888A (da) 1989-02-13
ATE132041T1 (de) 1996-01-15
DE3854829D1 (de) 1996-02-08
EP0308066A2 (en) 1989-03-22
EP0308066B1 (en) 1995-12-27
IE72103B1 (en) 1997-03-12
KR0131879B1 (ko) 1998-04-17
OA08901A (en) 1989-10-31
FI883763A0 (fi) 1988-08-12
KR890003402A (ko) 1989-04-14
PT88266A (pt) 1989-06-30
AU2053588A (en) 1989-04-20
PT88266B (pt) 1995-05-04
NO883594L (no) 1989-02-13
NO883594D0 (no) 1988-08-12
DK449888D0 (da) 1988-08-11
AU1001595A (en) 1995-02-23
JPH01131119A (ja) 1989-05-24
FI883763A (fi) 1989-02-13
RU1834663C (ru) 1993-08-15
EP0308066A3 (en) 1991-01-16
ZA885967B (en) 1989-07-26
CN1032740A (zh) 1989-05-10
NZ225799A (en) 1991-04-26

Similar Documents

Publication Publication Date Title
HUT47854A (en) Release in biological liquids of materials mediating the protection of host organism by systemic two-stranded rna treatment
BR8104189A (pt) Polipeptideos,sequencias de dna,veiculo de expressao,plasmideo,microorganismo,bacteria,linhagem de e.coli,composicao contendo polipeptideo,extrato,composicao farmaceutica,cultura de celulas microbiais,usos de alguns desses itens,e processos de preparacao
EP0400958A3 (en) Live vaccines
EP0500893A4 (en) Preservation of blood, tissues and biological fluids
KR890701722A (ko) 용해성 펩티드에 의한 진핵 병원체와 신생물의 억제 및 섬유 아세포와 임파구의 자극
IE862276L (en) PREVENTION AND TREATMENT OF AIDS WITH dsRNA
AU5684286A (en) Use of an aqueous, stabilised chlorite matrix solution for infectious conditions
PT87997A (pt) Processo para a preparacao de composicoes farmaceuticas uteis para a correccao de vias metabolicas aberrantes associadas com ciclos de crescimento descontrolados de celulas tumorais e de virus contendo arn de dupla cadeia
GB2250437B (en) A podophyllotoxin preparation containing triglycerides
Gentien et al. Modes of action of the toxic principle of Gyrodinium aureolum.
Zamshor et al. Beef-extract agar with sodium nucleinate as a medium for storage and stabilization of biological properties of shigellas.
Collins-Thompson et al. Food microbiology and biotechnology--an update.
Honda et al. Effects of sleep-promoting substances on the rat circadian sleep-waking cycles
Horsch et al. Infectious factorial diseases of farm animals.
Noto JINBUN RONSO
Chang Human trial for gene therapy
AU4849897A (en) Elaboration of host defense mediators into biological fluids by systemic dsRNA treatment
JPS5639098A (en) Novel oligosaccharide and its preparation
Kosmidis TREATMENT OF SERIOUS INFECTIONS WITH CEFTRIAXONE
KRISS Life processes and hydrostatic pressure(Russian book)
ITSP910003A0 (it) Procedimentodi difesa biologica dei vegetali e loro prodotti da attac-chi di organismi di natura micreobica e micellare tramite estrazione di principi attivi dal microrganismo o fungo stesso
PT914091E (pt) Solucoes contendo etileno e a sua utilizacao em metodos terapeuticos ou profilaticos
ES2194860T3 (es) Composiciones que contienen timosina alfa 1 destinadas al tratamiento de pacientes que sufren una enfermedad hepatica descompensada.

Legal Events

Date Code Title Description
DFC9 Refusal of application